Why Cannabis During Breastfeeding Carries Real Risks

Lipid-Mediated Transfer of THC into Breast Milk

Cannabinoids are highly lipophilic (fat-soluble) molecules. Because mammary glands are designed to produce milk with a high lipid content to support an infant’s rapid brain growth, they may facilitate a reservoir for Delta-9-tetrahydrocannabinol (THC).

THC partitions into breast milk at concentrations that can exceed those found in maternal plasma. Research indicates a milk-to-plasma ratio ranging from 3:1 to 8:1. In individuals who use cannabis chronically, THC is stored in adipose tissue and may be released steadily into the milk supply over extended periods, making it difficult to predict safe windows for nursing.

Fatty Acid Binding Proteins (FABPs) and Bioavailability

Cannabinoids use Fatty Acid Binding Proteins (FABPs) as transport chaperones. These proteins act as facilitators, moving THC across cellular membranes and through the infant’s digestive tract. By using this transport mechanism, THC may bypass the infant’s first-pass metabolism, potentially increasing the bioavailability of the compound in the infant’s systemic circulation compared to standard oral consumption in adults.

The Role of the ECS in Neonatal Development

The neonatal ECS is a fundamental regulator of central nervous system maturation. It is composed of G-protein coupled receptors (CB1 and CB2), endogenous ligands (Anandamide and 2-AG), and various metabolic enzymes.

Exogenous Interference with the Suckling Reflex

Human milk naturally contains the endocannabinoid 2-AG, which binds to CB1 receptors to help initiate and maintain the suckling reflex. When plant-derived THC enters the milk, it acts as an exogenous agonist. Because THC has a high affinity for these receptors, high concentrations may saturate the CB1 receptors. This interference may manifest as sedation, reduced feeding vigor, or poor weight gain in the neonate.

Neurodevelopmental Impact: CB1 Receptor Activation and Synaptic Pruning

Early brain development is defined by synaptogenesis (the formation of synapses) and synaptic pruning (the refinement of neural connections). The CB1 receptor serves as a chemical guide for axonal growth and neuronal migration.

Exogenous THC binding to these receptors during these critical windows may disrupt natural signaling pathways:

• Executive Function: Emerging data suggests that THC exposure during the first two years of life may correlate with alterations in the architecture of the prefrontal cortex.
• Motor Milestones: Clinical observations have suggested associations between THC exposure through breast milk and delayed motor development, such as reaching crawling and walking milestones at the 12-month mark.

Pharmacokinetics of Terpenes and CBD in Milk

Cannabis chemistry is not limited to THC. Cannabidiol (CBD) and volatile monoterpenes also enter the milk supply.

CBD Accumulation

Like THC, CBD is lipophilic and follows similar bioaccumulation pathways. It may inhibit the enzymes responsible for breaking down the body's natural endocannabinoids. There is a significant lack of longitudinal data regarding how supplemental CBD concentrations impact the development of an infant’s immune system and CB2 receptor sites.

Terpene Interaction

Terpenes such as Myrcene, Limonene, and Linalool are low-molecular-weight compounds capable of crossing the blood-brain barrier. While these are considered "Generally Recognized as Safe" (GRAS) for adults, their effect on a developing infant remains largely undocumented. These compounds may modify how cannabinoids bind to receptors—an "entourage effect" that may influence the sedative or psychoactive impact of THC on the infant.

The Inadequacy of the 'Pump and Dump' Method

The "pump and dump" strategy, commonly used for alcohol, is often physiologically ineffective for cannabis. Alcohol is water-soluble and leaves the milk as blood alcohol levels decline.

Because THC is stored in adipose (fat) cells, it is released into the bloodstream and milk supply continuously as the parent’s fat is metabolized.

• Detection Windows: In chronic users, THC may remain detectable in breast milk for up to six weeks after the final consumption.
• Occasional Use: Even with infrequent use, a single session creates a peak concentration window of 1 to 4 hours, with baseline levels persisting due to the slow terminal half-life of the molecule.

Harm Reduction and Quantitative Exposure Analysis

Major health organizations maintain that complete abstinence is the primary way to eliminate developmental risk. For those who continue to use cannabis, understanding delivery methods is a matter of harm reduction:

1. Route of Administration: Inhalation causes immediate, high-amplitude spikes in THC milk concentrations. Conversely, topicals generally fail to reach systemic circulation and may present a lower risk of transfer.
2. Environmental Exposure: Passive inhalation (second-hand smoke) offers a direct route for THC to enter the infant's bloodstream via the lungs, bypassing the filtration of maternal milk entirely.
3. Nutritional Consistency: If cannabis use occurred during pregnancy, the fetus was already exposed via the placenta. Pediatric consensus suggests that for many, clearing the cannabis while maintaining breastfeeding may be preferable to an immediate switch to formula, provided the infant's developmental milestones are closely monitored by a physician.

---

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Bertrand KA, Hanan NJ, Honerkamp-Smith G, Best BM, Chambers CD. (2018). Marijuana use by breastfeeding mothers and cannabinoid concentrations in breast milk. Pediatrics. 142(3):e20181076. PubMed

2. Devine EA, Roistacher K, Bhupinder S, Chandra S. (2023). Cannabinoid concentrations in breast milk and infant exposures. Obstet Gynecol. (Review). PubMed

3. Hale TW, Melnikova N. (2020). Cannabis use during lactation. J Hum Lact. 36(2):195-199. PubMed

4. Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M. (1994). Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience. 63(3):637-52. PubMed

5. Fride E. (2004). The endocannabinoid-CB1 receptor system in pre- and postnatal life. Eur J Pharmacol. 500(1-3):289-97. PubMed